Prevalence of β₂-agonist inhalation for outpatients in a pediatric emergency center during enterovirus D68 epidemic
Asia Pacific Allergy
;
(4): e16-2018.
Article
in English
| WPRIM
| ID: wpr-750139
ABSTRACT
BACKGROUND:
Enterovirus D68 (EV-D68) has been reported to have caused severe bronchial asthma attacks and hospitalization epidemics in Japan in September 2015.OBJECTIVE:
To investigate the prevalence of β2-agonist inhalation in a pediatric emergency center during a period of increased hospitalization for bronchial asthma, which was suggested to be associated with EV-D68.METHODS:
We investigated the prevalence of β2-agonist inhalation in a pediatric emergency center in Saga city, Japan, from April 2013 to October 2015, and also clarified the trends in bronchial asthma hospitalization in the same area during that time.RESULTS:
The prevalence of β2-agonist inhalation in the pediatric emergency center, September 2015 was highest when EV-D68 became widespread. The monthly average for β2-agonist inhalation during the study period was 91 cases, but the count in September 2015 was 255 cases. Hospitalized cases of bronchial asthma in September 2015 were increased for age ≥3 years and not increased for age <3 years, but the prevalence of β2-agonist inhalation at the pediatric emergency center was increased even under the age of 3 years.CONCLUSION:
During the epidemic period for EV-D68, cases requiring β2-agonist inhalation were increased. The EV-D68 epidemic may be related to not only severe cases requiring hospitalization, but also exacerbation of relatively mild symptoms of bronchial asthma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Outpatients
/
Asthma
/
Inhalation
/
Prevalence
/
Enterovirus
/
Emergencies
/
Hospitalization
/
Japan
Type of study:
Prevalence study
/
Risk factors
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Asia Pacific Allergy
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS